Droncit Canine is only for use in dogs. Droncit Feline
is only for use in cats. Droncit Injectable is only for use in cats
and dogs. Do not administer to other animals. Give this medication only
to animals for which it was prescribed. Not for use in humans.
Read all instructions and precautionary statements
from the manufacturer.
Use exactly as prescribed by your veterinarian.
Directions for Droncit Canine:
- Do not fast your dog before or after administration.
- Feed tablets directly by hand or crumble and add
them to a small amount of food.
- Give ½ tablet to dogs weighing less than 5 lbs.
- Give 1 tablet to dogs weighing 6-10 lbs.
- Give 1 ½ tablets to dogs weighing 11-15 lbs.
- Give 2 tablets to dogs weighing 16-30 lbs.
- Give 3 tablets to dogs weighing 31-45 lbs.
- Give 4 tablets to dogs weighing 46-60 lbs.
- Give 5 tablets to dogs weighing more than 60 lbs.
- Do not exceed a 5-tablet dose.
Directions for Droncit Feline:
- Do not fast your cat before or after administration.
- Feed tablets directly by hand or crumble and add
them to a small amount of food.
- Give ½ tablet to cats weighing 4 lbs. or less.
- Give 1 tablet to cats weighing 5-11 lbs.
- Give 1 ½ tablets to cats weighing more than 11 lbs.
- Do not exceed a 1 ½ tablet dose.
Directions for Droncit Injectable:
- Inject Droncit intramuscularly or subcutaneously.
- Sterilize the site of injection and the syringe.
- Give 0.3 mL to dogs weighing 5 lbs. or less.
- Give 0.5 mL to dogs weighing 6-10 lbs.
- Give 1.0 mL to dogs weighing 11-25 lbs.
- Give 0.2 mL per 5 lbs. of body weight to dogs weighing
more than 25 lbs.
- Do not exceed a 3.0 mL dose in dogs.
- Give 0.2 mL to cats weighing less than 5 lbs.
- Give 0.4 mL to cats weighing 5-10 lbs.
- Give 0.6 mL to cats weighing more than 10 lbs.
- Do not exceed a 0.6 mL dose in cats.
Frequency of Use:
Droncit requires a single dose to treat a tapeworm
infection. Sometimes a second treatment is necessary. Your veterinarian
may suggest a regular treatment schedule every 21 to 26 days for control
of E. multilocularis tapeworms.
Storage:
Keep out of reach of children and animals.
Store Droncit tablets at room temperature, protected
from moisture and heat. Store Droncit Injectable at room temperature,
protected from heat.
It is a violation of Federal
Law to use this product in a manner inconsistent with its labeling.
Praziquantel, the single active ingredient in Droncit,
damages the tapeworm's skin in such a way that it cannot continue
to resist digestion by its host. While tapeworms are usually fully digested,
in some instances pieces may be seen in the stool.
Droncit requires a prescription from your veterinarian.
Droncit (praziquantel)
Droncit Canine Active Ingredient
(per tablet): praziquantel 34 mg
Droncit Feline Active Ingredient
(per tablet): praziquantel 23 mg
Droncit Injectable Active Ingredient
(per mL): praziquantel 56.8
Warnings:
Keep Droncit out of reach of children and animals.
Do not use or store in or near open flame or heat.
Use Droncit Canine only in dogs. Use Droncit Feline
only in cats. Use Droncit Injectable only in cats and dogs. Use only
in the animal for which it was prescribed. Do not administer to other
animals. Not for use in humans.
Follow the specifications of your veterinarian's
prescription.
CAUTION: Droncit is not for dogs younger
than 4 weeks of age or for cats younger than 6 weeks of age.
Do not exceed stated maximum doses.
Tapeworms may infect humans and other animals. Talk
to your veterinarian about proper hygiene and preventive procedures.
Side effects may include vomiting, diarrhea, loss
of appetite, or lethargy. Mention any observed adverse reactions to
your veterinarian.
Some irritation may appear at the site of injection
after administration of Droncit Injectable.
Sterilization of the site of injection and syringe
helps prevent infections.
Droncit has been tested in breeding and pregnant
cats and dogs. No adverse reactions were observed.
If you know of or suspect an overdose, contact your
veterinarian right away.
Consult your veterinarian before concurrently administering
other drugs or supplements. Do not give Droncit concomitantly with another
tapeworm medication unless expressly instructed to do so by your veterinarian.
Elimination of fleas on your pet is important for
preventing reinfection with tapeworms.
Warranty and Manufacturer Information:
Droncit is a Reg. TM of the parent company of Bayer
AG, Leverkusen.
Bayer HealthCare LLC, Animal Health Division, Shawnee
Mission, Kansas 66201 U.S.A.
Bayer, the Bayer Cross, and Droncit are trademarks
of Bayer.
For customer service or to obtain product information,
including Material Safety Data Sheet, call 1-800-633-3796. For medical
emergencies or to report adverse reactions, call 1-800-422-9874.
Droncit Canine:
July, 2007
08957811, R.1
13512
NADA 111-798, Approved by FDA
Droncit Feline:
July, 2007
08954391, R.1
13509
NADA 111-798, Approved by FDA
Droncit Injectable:
December, 2003
08715559-79018310, R.13
NADA # 111-607, Approved by FDA